| Literature DB >> 31198552 |
Emad Hamdy Gad1, Hazem Zakaria1, Yasmin Kamel2, Ayman Alsebaey3, Talat Zakareya3, Mohamed Abbasy3, Anwar Mohamed3, Ali Nada3, Mohammed Alsayed Abdelsamee4, Mohamed Housseni4.
Abstract
OBJECTIVES: For complicated common bile duct stones (CBDS) that cannot be extracted by endoscopic retrograde cholangiopancreatography (ERCP), management can be safely by open or laparoscopic CBD exploration (CBDE). The study aimed to assess these surgical procedures after endoscopic failure.Entities:
Keywords: CBD stones; Laparoscopic CBDE; Open CBDE
Year: 2019 PMID: 31198552 PMCID: PMC6556483 DOI: 10.1016/j.amsu.2019.05.007
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Fig. 1A: Laparoscopic cholecodoscopic view of CBD stone, B: laparoscopic cholecodoscopic stone extraction, C: laparoscopic primary closure of CBD.
Fig. 2(a,b) laparoscopic stone and stent extraction, ©: laparoscopic HJ.
Fig. 3a: OCBD extraction of stent and stone. b: Open primary closure of CBD.
Fig. 4a, b, OCBD extraction of stent and stones. c,d: Open T-tube insertion, and T-tube cholangiogram.
Fig. 5a: A cholecodoscopic view of stone in RT hepatic duct. b: Open cholecodoscopic basket extraction.
Fig. 6a: An open cholecodocoscopic view of stone and stent in distal CBD, b,c: cholecodoscopic extraction of stent and stone with duodenal mucosa appearance.
Characteristics of patients regarding demographics and ERCP.
| Character | (Mean ± SD) or | |
|---|---|---|
| No | (%) | |
| Gender | ||
| Males | 27 | (68.2%) |
| Females | 58 | (31.8%) |
| Age(years) (Mean ± SD) | 45.1 ± 11.5 | |
| Pre ERCP main presentation | ||
| Acute cholecystitis | 5 | (5.9%) |
| Biliary colic | 35 | (41.2%) |
| Cholangitis | 5 | (5.9%) |
| Jaundice | 36 | (42.4%) |
| Pancreatitis | 4 | (4.7%) |
| No of ERCP sessions | ||
| Single | 67 | (78.8%) |
| Multiple | 18 | (21.2%) |
| Cause of ERCP failure | ||
| Very large stones(<2 cm) | 13 | (15.3%) |
| Multiple large stones | 17 | (20%) |
| Impacted large stones | 51 | (60%) |
| Failed cannulation | 4 | (4.7%) |
| Post ERCP complications | 8 | (9.4%) |
| Bleeding | 2 | (2.4%) |
| Cholangitis | 2 | (2.4%) |
| Impacted dormia | 1 | (1.2%) |
| Pancreatitis | 3 | (3.5%) |
ERCP: Endoscopic retrograde cholangio-pancreatography.
Comparison between LCBDE, and OCBDE, and characteristics of the 4 converted cases.
| Character | LCBDE (No = 21) (Mean ± SD) Or No (%) | OCBDE (No = 60) (Mean ± SD) or No (%) | P value Univariate analysis | P value Multivariate analysis | The converted cases (No = 4) (Mean ± SD) |
|---|---|---|---|---|---|
| Gender | >0.05 | ||||
| Males | 6(28.6%) | 20 (33.3%) | 1(25%) | ||
| Females | 15(71.4%) | 40 (66.7%) | 3(75%) | ||
| Age(years) | 34.05 ± 6.1 | 49.6 ± 9.9 | 0.000 | 0.05 | 36.3 ± 13.5 |
| Site of stones | 0.001 | >0.05 | |||
| CHD | 3(14.3%) | 0 | 0 | ||
| Mid-CBD | 15(71.4%) | 29(48.3%) | 2(50%) | ||
| Distal CBD | 3(14.3%) | 26(43.3%) | 2(50%) | ||
| Ampulla | 0 | 5(8.3%) | 0 | ||
| CBD diameter(mm) | 14 ± 4.7 | 15.4 ± 5.02 | >0.05 | 14.3 ± 5.7 | |
| Stone size | 0.1 | >0.05 | |||
| Large(1.5–2 cm) | 18(85.7%) | 43(71.7%) | 3(75%) | ||
| Very large(<2 cm) | 3(14.3%) | 17(28.3%) | 1(25%) | ||
| NO of stones | >0.05 | ||||
| Single | 19(90.5%) | 46(76.7%) | 1(25%) | ||
| Multiple | 2(9.5%) | 14(23.3%) | 3(75%) | ||
| Nature of stones | >0.05 | ||||
| Primary | 1(4.8%) | 1(1.7%) | 1(25%) | ||
| Secondary | 20(95.2%) | 59(98.3%) | 3(75%) | ||
| ASA score | >0.05 | ||||
| I | 14 (66.7%) | 40 (66.7%) | 3(75%) | ||
| II | 6 (28.6%) | 16 (26.7%) | 1(25%) | ||
| III | 1(4.8%) | 4(6.7%) | 0 | ||
| Type of operation | |||||
| LCD | 0 | 0.000 | 4(100%) | ||
| OCD | 0 | 55(91.7%) | 0.000 | 4(100%) | |
| TDS | 0 | 5(8.3%) | 0.1 | 0 | |
| IOC | 21(100%) | 60(100%) | 4(100%) | ||
| choledochoscope | 21(100%) | 38(63.3%) | 0.001 | >0.05 | 4(100%) |
| Primary repair | 9(42.9%) | 30(50%) | >0.05 | 0 | |
| T- tube | 11(52.4%) | 20(33.3%) | 0.1 | >0.05 | 3(75%) |
| HJ | 1(4.8%) | 5(8.3%) | >0.05 | 1(25%) | |
| Operative bleeding | 1(4.8%) | 2(3.3%) | >0.05 | 1(25%) | |
| Operative time(min) | 231.4 ± 49.3 | 160.7 ± 43.4 | 0.000 | 0.02 | 345 ± 13 |
| Post-operative hospital stay(days) | 5.5 ± 3 | 6.1 ± 2.1 | >0.05 | 8 ± 1.4 | |
| Postoperative | |||||
| complications | 3(14.3%) | 7(11.7%) | >0.05 | >0.05 | 1(25%) |
| Chest infection | 1(4.8%) | 5(8.3%) | >0.05 | 1(25%) | |
| Wound infection | 1(4.8%) | 2(3.3%) | >0.05 | 0 | |
| Missed stones | 1(4.8%) | 3(5%) | >0.05 | 0 | |
| Bile leak | 2(9.5%) | 0 | 0.06 | 0 | |
| Stricture | 0 | 0 | |||
| Recurrent stones | 0 | 0 | |||
| Stone clearance rate | 20 (95.2%) | 57(95%) | >0.05 | 4(100%) | |
| Mortality | 0 | 0 | 0 | ||
LCBDE: Laparoscopic common bile duct exploration, OCBDE: Open common bile duct exploration, CHD: Common hepatic duct, CBD: Common bile duct, ERCP: Endoscopic retrograde cholangiopancreatography, ASA: American society of anaesthesia, LCD: Laparoscopic choledochotomy, OCD: Open choledochotomy, TDS: Transduodenal sphinectroplasty, IOC: Intra-operative cholangiogram, HJ: Hepaticojejunostomy.
T- tube insertion VS primary closure of CBD (LCBDE group).
| Character | T- tube (No = 11) (Mean ± SD) or No (%) | Primary closure (No = 9) (Mean ± SD) or No (%) | P value Univariate analysis | P value Multivariate analysis |
|---|---|---|---|---|
| ASA score | ||||
| I | 7(63.6%) | 6(66.7%) | >0.05 | |
| II | 3(27.3%) | 3(33.3%) | ||
| III | 1(9.1%) | 0 | ||
| CBD diameter(mm) | 13.3 ± 5.6 | 13.4 ± 0.9 | ||
| No of stones | 0.1 | <0.05 | ||
| Single | 9(81.8%) | 9(100%) | ||
| Multiple | 2(18.2%) | 0 | ||
| Operative time(min) | 263.6 ± 37.8 | 191.1 ± 32.2 | 0.000 | <0.05 |
| Hospital stay(days) | 7.6 ± 1 | 3 ± 2.6 | 0.001 | <0.05 |
| Postoperativ | ||||
| complications | 2(18.2%) | 1(11.1%) | >0.05 | |
| Chest infection | 1(9.1%) | 0 | >0.05 | |
| Wound infection | 1(9.1%) | 0 | >0.05 | |
| Missed stones | 1(9.1%) | 0 | >0.05 | |
| Bile leak | 1(9.1%) | 1(11.1) | >0.05 | |
| Stricture | 0 | 0 | ||
| Recurrent stones | 0 | 0 | ||
| Success rate | 10(90.9%) | 9(100%) | >0.05 | |
ASA: American society of anesthesia, CBD: Common bile duct.
T- tube insertion vs. primary CBD closure in OCBDE group.
| Character | T- tube (No = 20) (Mean ± SD)or No (%) | Primary closure (No = 30) (Mean ± SD) or No (%) | P value Univariate analysis | P value Multivariate analysis |
|---|---|---|---|---|
| ASA score | ||||
| I | 15(75%) | 21(70%) | ||
| II | 3(15%) | 7(23.3%) | ||
| III | 2(10%) | 2(6.7%) | ||
| CBD diameter(mm) | 19.7 ± 4.8 | 11.8 ± 2 | 0.000 | >0.05 |
| No of stones | 0.000 | >0.05 | ||
| Single | 8 (40%) | 30(100%) | ||
| Multiple | 12(60%) | 0 | ||
| choledochoscope | 7(35%) | 29(96.7%) | 0.000 | >0.05 |
| Operative time(min) | 177.5 ± 17.1 | 125.3 ± 15.9 | 0.000 | >0.05 |
| Hospital stay(days) | 7.8 ± 0.8 | 4.4 ± 1.4 | 0.000 | >0.05 |
| Postoperative | ||||
| complications | 3(15%) | 3(10%) | >0.05 | |
| Chest infection | 2(10%) | 3(10%) | >0.05 | |
| Wound infection | 1(5%) | 0 | >0.05 | |
| Missed stones | 3(15%) | 0 | 0.05 | >0.05 |
| Bile leak | 0 | 0 | ||
| Stricture | 0 | 0 | ||
| Recurrent stones | 0 | 0 | ||
| Success rate | 17(85%) | 30(100%) | 0.05 | >0.05 |
ASA: American society of anesthesia, CBD: Common bile duct.
Choledochoscope usage in OCBDE group.
| Character | Choledochoscope (No = 38) (Mean ± SD) or No (%) | No choledochoscope (No = 22) (Mean ± SD) or No (%) | P value Univariate analysis | P value Multivariate analysis |
|---|---|---|---|---|
| ASA score | ||||
| I | 25(65.8%) | 15(68.2%) | >0.05 | |
| II | 10(26.3%) | 6(27.3%) | ||
| III | 3(7.9%) | 1(4.5%) | ||
| Primary repair | 29(76.3%) | 1(4.5%) | 0.000 | 0.02 |
| T- tube | 7(18.4%) | 13(59.1%) | 0.002 | <0.05 |
| Operative bleeding | 2(5.3%) | 0 | <0.05 | <0.05 |
| Operative time(min) | 140.8 ± 36.1 | 195 ± 32.3 | 0.000 | <0.05 |
| Hospital stay(days) | 5.3 ± 2 | 7.3 ± 1.4 | 0.000 | 0.06 |
| Postoperative | ||||
| complications | 4(10.5%) | 3(13.6%) | <0.05 | |
| Chest infection | 3(7.9%) | 2(9.1%) | <0.05 | |
| Wound infection | 1(2.6%) | 1(4.5%) | <0.05 | |
| Missed stones | 0 | 3(13.6%) | 0.04 | <0.05 |
| Bile leak | 0 | 0 | ||
| Stricture | 0 | 0 | ||
| Recurrent stones | 0 | 0 | ||
| Stone clearance rate | 38(100%) | 19(86.4%) | 0.04 | <0.05 |
ASA: American society of anesthesia.